ArticleFrontiers in toxicology2025
Proliferation and metabolic activity of the Atlantic sturgeon cell line AOXlar7y under short-term serum-reduced conditions, and the effect of stimulation with growth factors and cytokines.
Article in Frontiers in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- First Evidence of Functional Neuronal Remodeling In Vitro in a Cell Line from an Evolutionarily Ancient Vertebrate (Sturgeon).Cellular and molecular neurobiology · 2026Article
- Towards Cost-Effective and Sustainable Media Formulations for Terrestrial and Aquatic Cellular Agriculture.Foods (Basel, Switzerland) · 2026Review
- dia-PASEF Enables Rapid Profiling of the Human Secretome for Deeper Insights Into Cellular Dynamics and Inflammatory Mechanisms.Molecular & cellular proteomics : MCP · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Fish cell lines represent a powerful tool for studying the biology and toxicology of aquatic species in compliance with the 3Rs principles. In addition, they hold potential for more advanced biotechnological applications. However, fish cell cultures are mainly cultivated with fetal bovine serum. Therefore, in this study, we investigated the impact of serum reduction and the effects of six growth factors and cytokines on a sturgeon larval cell line (AOXla7y), which has been previously proven to be a valuable model for climate change and toxicology studies. Methods: The serum reduction (from 10% to 5% and 2%) and the addition of two concentrations (10 and 50 ng/mL) of six growth factors and cytokines (FGF-2, IGF-1, LIF, IFN-γ, IL-13, and IL-15) to the 2% serum growth medium were evaluated over 6 days of cultivation. The morphology and cell density were determined using phasecontrast images after the experiment ended, while real-time label-free cell impedance (xCELLigence) was recorded throughout the cultivation period. Moreover, the end-point oxygen consumption in basal and uncoupled respiration conditions was analyzed with the Seahorse XF Cell Mito Stress Test Kit. Results: The results demonstrated a general adaptation of the sturgeon cell line to a serum-reduced environment and the modulatory effects of growth factor and cytokine supplementation on cell growth and metabolism. Discussion: These findings suggest that the sturgeon cell line has the potential to transition to a serumfree medium without major observed morphological modifications and with a limited reduction in proliferation. Its metabolism was differentially modulated by the signaling of growth factors and cytokines and exhibited a variable metabolic phenotype under mitochondrial stress. This study provides a characterization of the Atlantic sturgeon cell metabolism and offers a preliminary assessment for developing an animal-free and chemically defined medium.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.